Medtech Insights

The US large-joint reconstructive implant market is characterized by its balance of competing priorities—strong functional outcomes and cost-effectiveness. Innovation in peripheral technology…

The diagnostic imaging system market in Japan is relatively mature and has a saturated installed base of large imaging systems—namely MRI and CT systems. However, due to an increasingly…

Through 2023, downward pricing pressures will mitigate some of the positive procedure volume growth resulting from favorable demographics in Europe. This Medtech 360 Report provides key market…

The Japanese IC market is large but mature. Saturated adoption of PCI techniques and slow expansion of the CADpopulation will result in low procedural growth. However, favorable reimbursement…

While sustained procedure volume growth and adoption of some premium-priced products will drive moderate revenue growth in the US trauma device market, significant cost-containment pressures will…

Through 2023, downward pricing pressures will mitigate some of the positive procedure volume growth resulting from favorable demographics in Europe. This Medtech 360 Report provides…

The European market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of …

The Asia Pacific interventional oncology device market is one of the largest and fastest growing spaces in interventional medicine. Despite pricing pressures and high competition negatively…

The Latin American market for surgical hemostats, internal tissue sealants, and adhesion barriers represents a high-growth market with relatively low penetration compared to countries like the US,…

The European market for clot management devices consists of a mixture of quickly expanding and relatively mature market segments, encompassing a wide variety of products used in the treatment of …

The Latin American market for surgical hemostats, internal tissue sealants, and adhesion barriers represents a high-growth market with relatively low penetration compared to countries like the US,…

The Asia Pacific interventional oncology device market is one of the largest and fastest growing spaces in interventional medicine. Despite pricing pressures and high competition negatively…